117 related articles for article (PubMed ID: 9589386)
21. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
[TBL] [Abstract][Full Text] [Related]
22. Gender differences in CNS autoimmunity induced by mimicry epitope for PLP 139-151 in SJL mice.
Massilamany C; Thulasingam S; Steffen D; Reddy J
J Neuroimmunol; 2011 Jan; 230(1-2):95-104. PubMed ID: 20950867
[TBL] [Abstract][Full Text] [Related]
23. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H
J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089
[TBL] [Abstract][Full Text] [Related]
24. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
[TBL] [Abstract][Full Text] [Related]
25. Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis.
Bebo BF; Zelinka-Vincent E; Adamus G; Amundson D; Vandenbark AA; Offner H
J Neuroimmunol; 1998 Apr; 84(2):122-30. PubMed ID: 9628453
[TBL] [Abstract][Full Text] [Related]
26. Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
Wegmann KW; Archie Bouwer HG; Whitham RH; Hinrichs DJ
J Neuroimmunol; 2014 Sep; 274(1-2):46-52. PubMed ID: 24997489
[TBL] [Abstract][Full Text] [Related]
27. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
Peng Y; Liu CP
Chin Med J (Engl); 2002 Apr; 115(4):521-4. PubMed ID: 12133288
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 7 is a potent co-stimulator of myelin specific T cells that enhances the adoptive transfer of experimental autoimmune encephalomyelitis.
Bebo BF; Schuster JC; Adlard K; Vandenbark AA; Offner H
Cytokine; 2000 Apr; 12(4):324-31. PubMed ID: 10805212
[TBL] [Abstract][Full Text] [Related]
29. The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells.
Hofstetter HH; Grau C; Buttmann M; Forsthuber TG; Gaupp S; Toyka KV; Gold R
Cytokine; 2007 Oct; 40(1):35-43. PubMed ID: 17881243
[TBL] [Abstract][Full Text] [Related]
30. Adoptively transferred experimental autoimmune encephalomyelitis in SJL/J, PL/J, and (SJL/J x PL/J)F1 mice. Influence of I-A haplotype on encephalitogenic epitope of myelin basic protein.
McCarron R; McFarlin DE
J Immunol; 1988 Aug; 141(4):1143-9. PubMed ID: 3260919
[TBL] [Abstract][Full Text] [Related]
31. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.
Kuchroo VK; Anderson AC; Waldner H; Munder M; Bettelli E; Nicholson LB
Annu Rev Immunol; 2002; 20():101-23. PubMed ID: 11861599
[TBL] [Abstract][Full Text] [Related]
32. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system.
Denkinger CM; Denkinger M; Kort JJ; Metz C; Forsthuber TG
J Immunol; 2003 Feb; 170(3):1274-82. PubMed ID: 12538686
[TBL] [Abstract][Full Text] [Related]
33. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
Sobel RA; Kuchroo VK
J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
[TBL] [Abstract][Full Text] [Related]
34. Differential recognition of peptide analogs by naive verses activated PLP 139-151-specific CD4+ T cells.
McRae BL; Nikcevich KM; Karpus WJ; Hurst SD; Miller SD
J Neuroimmunol; 1995 Jul; 60(1-2):17-28. PubMed ID: 7543908
[TBL] [Abstract][Full Text] [Related]
35. L-Selectin-deficient SJL and C57BL/6 mice are not resistant to experimental autoimmune encephalomyelitis.
Uboldi C; Döring A; Alt C; Estess P; Siegelman M; Engelhardt B
Eur J Immunol; 2008 Aug; 38(8):2156-67. PubMed ID: 18651702
[TBL] [Abstract][Full Text] [Related]
36. Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis.
Reddy J; Waldner H; Zhang X; Illes Z; Wucherpfennig KW; Sobel RA; Kuchroo VK
J Immunol; 2005 Nov; 175(9):5591-5. PubMed ID: 16237044
[TBL] [Abstract][Full Text] [Related]
37. A gene therapy approach for treating T-cell-mediated autoimmune diseases.
Chen C; Rivera A; Ron N; Dougherty JP; Ron Y
Blood; 2001 Feb; 97(4):886-94. PubMed ID: 11159513
[TBL] [Abstract][Full Text] [Related]
38. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor.
Waldner H; Whitters MJ; Sobel RA; Collins M; Kuchroo VK
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3412-7. PubMed ID: 10737797
[TBL] [Abstract][Full Text] [Related]
39. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage.
Kuchroo VK; Sobel RA; Laning JC; Martin CA; Greenfield E; Dorf ME; Lees MB
J Immunol; 1992 Jun; 148(12):3776-82. PubMed ID: 1376341
[TBL] [Abstract][Full Text] [Related]
40. Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis.
Nicolò C; Sali M; Di Sante G; Geloso MC; Signori E; Penitente R; Uniyal S; Rinaldi M; Ingrosso L; Fazio VM; Chan BM; Delogu G; Ria F
J Immunol; 2010 Jan; 184(1):222-35. PubMed ID: 19949067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
